All Stories

  1. Novel Approaches to Anti-atherosclerotic Therapy: Cell-based Models and Herbal Preparations (Review of Our Own Data)
  2. Role of androgens in cardiovascular pathology
  3. Engineered Nanoparticles: Their Properties and Putative Applications for Therapeutic Approaches Utilizing Stem Cells for the Repair of Atherosclerotic Disease
  4. Chemokines and Relevant microRNAs in the Atherogenic Process
  5. Epigenetic Alterations in DNA and Histone Modifications Caused by Depression and Antidepressant Drugs: Lessons from the Rodent Models
  6. Dendritic Cells in Colorectal Cancer and a Potential for their Use in Therapeutic Approaches
  7. Links between atherosclerotic and periodontal disease
  8. Cardiac Extracellular Vesicles in Normal and Infarcted Heart
  9. Dendritic Cells in Esophageal Adenocarcinoma: The Currently Available Information and Possibilities to use Dendritic Cells for Immunotherapeutic Approaches
  10. Endothelial Barrier and Its Abnormalities in Cardiovascular Disease
  11. Neutrophil's weapons in atherosclerosis
  12. Macrophage‐mediated cholesterol handling in atherosclerosis
  13. Vascular stem/progenitor cells: current status of the problem
  14. Myeloid dendritic cells: Development, functions, and role in atherosclerotic inflammation
  15. Range-wide population structure of European sea bassDicentrarchus labrax
  16. Changes in transcriptome of macrophages in atherosclerosis
  17. Heterogeneity of Tregs and the complexity in the IL-12 cytokine family signaling in driving T-cell immune responses in atherosclerotic vessels
  18. Extracellular vesicles and atherosclerotic disease
  19. Macrophage phenotypic plasticity in atherosclerosis: The associated features and the peculiarities of the expression of inflammatory genes
  20. Vascular Endothelium: Functioning in Norm, Changes in Atherosclerosis and Current Dietary Approaches to Improve Endothelial Function
  21. Intestinal mucosal tolerance and impact of gut microbiota to mucosal tolerance
  22. Novel Anti-inflammatory Interleukin-35 as an Emerging Target for Antiatherosclerotic Therapy
  23. Molecular characteristics of patients with glycosaminoglycan storage disorders in Russia
  24. Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation
  25. Modified Low Density Lipoprotein and Lipoprotein-Containing Circulating Immune Complexes as Diagnostic and Prognostic Biomarkers of Atherosclerosis and Type 1 Diabetes Macrovascular Disease
  26. Studying progression from glucose intolerance to type 2 diabetes in obese children
  27. Extracellular vesicles shed by glioma cells: pathogenic role and clinical value
  28. Dendritic cells in atherosclerotic inflammation: the complexity of functions and the peculiarities of pathophysiological effects
  29. Genetic Analysis of 17 Children with Hunter Syndrome: Identification and Functional Characterization of Four Novel Mutations in the Iduronate-2-Sulfatase Gene
  30. Analysis of expression of microRNAs and genes involved in the control of key signaling mechanisms that support or inhibit development of brain tumors of different grades
  31. Genetic background of juvenile idiopathic arthritis
  32. Role of Bone-Type Tissue-Nonspecific Alkaline Phosphatase and PHOSPO1 in Vascular Calcification
  33. Mitochondrial Aging and Age-Related Dysfunction of Mitochondria
  34. Mitochondrial Mutations in Atherosclerosis: New Solutions in Research and Possible Clinical Applications
  35. Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy
  36. WITHDRAWN: Dendritic cells: A double-edge sword in atherosclerotic inflammation
  37. Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response
  38. Vascular Extracellular Matrix in Atherosclerosis
  39. Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology
  40. Endophenotypes as a measure of suicidality
  41. The heteroplasmic 15059G>A mutation in the mitochondrial cytochrome b gene and essential hypertension in type 2 diabetes
  42. Contribution of microRNAs to radio- and chemoresistance of brain tumors and their therapeutic potential
  43. Skipping breakfast is correlated with impaired fasting glucose in apparently healthy subjects
  44. Liver Regenerative Medicine: Advances and Challenges
  45. Mitochondrial dysfunction and mitochondrial DNA mutations in atherosclerotic complications in diabetes
  46. The rs11705701 G>A Polymorphism of IGF2BP2 is Associated With IGF2BP2 mRNA and Protein Levels in the Visceral Adipose Tissue - A Link to Type 2 Diabetes Susceptibility
  47. Genetic determinants of aggression and impulsivity in humans
  48. Diabetic retinopathy: Pathogenic mechanisms and current treatments
  49. The carriage of risk variants of CDKAL1 impairs beta-cell function in both diabetic and non-diabetic patients and reduces response to non-sulfonylurea and sulfonylurea agonists of the pancreatic KATP channel
  50. How to fight with senescent cells?
  51. The carriage of the type 1 diabetes-associated R262W variant of human LNK correlates with increased proliferation of peripheral blood monocytes in diabetic patients
  52. Genetic Markers of Graves’ Disease: A Historical View and Up-date
  53. The −112G > A polymorphism of the secretoglobin 3A2 (SCGB3A2) gene encoding uteroglobin-related protein 1 (UGRP1) increases risk for the development of Graves’ disease in subsets of patients with elevated levels of immunoglobulin E
  54. Loss-of-function mutations E6 27X and I923V of IFIH1 are associated with lower poly(I:C)–induced interferon-β production in peripheral blood mononuclear cells of type 1 diabetes patients
  55. T-cell protein tyrosine phosphatase: A role in inflammation and autoimmunity
  56. Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population
  57. Interferon Induced with Helicase C Domain 1 (IFIH1) and Virus-Induced Autoimmunity: A Review
  58. Advanced age, low left atrial appendage velocity, and Factor V promoter sequence variation as predictors of left atrial thrombosis in patients with nonvalvular atrial fibrillation
  59. Ligase IV Syndrome
  60. Replication of association between polymorphisms of the pancreatic ATP-sensitive potassium channel and susceptibility to type 2 diabetes in two Russian urban populations
  61. Endogenous and exogenous stem cells: a role in lung repair and use in airway tissue engineering and transplantation
  62. A WFS1 Haplotype Consisting of the Minor Alleles of rs752854, rs10010131, and rs734312 Shows a Protective Role Against Type 2 Diabetes in Russian Patients
  63. TCF7L2 rs12255372 and SLC30A8 rs13266634 confer susceptibility to type 2 diabetes in a Russian population
  64. Ligase IV syndrome
  65. Zn2+-transporter-8: A dual role in diabetes
  66. Genetic evolution and diversity of common carp Cyprinus carpio L.
  67. A Splice Variant of GNB3 and Peripheral Polyneuropathy in Type 1 Diabetes
  68. The KCNJ11 E23K and ABCC8 exon 31 variants contribute to susceptibility to type 2 diabetes, glucose intolerance and altered insulin secretion in a Russian population
  69. Identification of New Susceptibility Genes for Type 1 Diabetes: An Update
  70. The crucial role of IL-2/IL-2RA-mediated immune regulation in the pathogenesis of type 1 diabetes, an evidence coming from genetic and animal model studies
  71. Leu54Phe and Val762Ala polymorphisms in the poly(ADP-ribose)polymerase-1 gene are associated with diabetic polyneuropathy in Russian type 1 diabetic patients
  72. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients
  73. Adiponectin and Adiponectin Receptor Gene Variants in Relation to Type 2 Diabetes and Insulin Resistance-Related Phenotypes
  74. Cytotoxic T-Lymphocyte Associated Antigen 4 Gene Polymorphisms and Autoimmune Thyroid Disease: A Meta-Analysis
  75. Is FCRL3 a New General Autoimmunity Gene?
  76. Review on the immunology of European sea bass Dicentrarchus labrax
  77. Current strategies and perspectives in insulin gene therapy for diabetes
  78. Microsatellites and their genomic distribution, evolution, function and applications: A review with special reference to fish genetics
  79. Genetic analysis and functional evaluation of the C/T(−318) and A/G(−1661) polymorphisms of the CTLA-4 gene in patients affected with Graves' disease
  80. A Microsatellite Linkage Map of the European Sea Bass Dicentrarchus labrax L.
  81. The TAF5L gene on chromosome 1q42 is associated with type 1 diabetes in Russian affected patients
  82. Confirmation of a susceptibility locus for diabetic nephropathy on chromosome 3q23–q24 by association study in Russian type 1 diabetic patients
  83. Thyroid-stimulating hormone receptor and its role in Graves’ disease
  84. CTLA-4 and its role in autoimmune thyroid disease